Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	glutamate receptor activity	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	6.85e-08	27	80	5	GO:0008066
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.05e-07	57	80	6	GO:1904315
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 DDX43 OLA1 FANCM DNAH6 DHX29 TOP2B	1.35e-07	614	80	14	GO:0140657
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.44e-07	60	80	6	GO:0099529
GeneOntologyMolecularFunction	ATP hydrolysis activity	KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 DDX43 OLA1 FANCM DNAH6 DHX29	1.80e-07	441	80	12	GO:0016887
GeneOntologyMolecularFunction	transmitter-gated channel activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.34e-07	65	80	6	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.34e-07	65	80	6	GO:0022824
GeneOntologyMolecularFunction	AMPA glutamate receptor activity	GRIA2 GRIA3 GRIA4	2.47e-07	4	80	3	GO:0004971
GeneOntologyMolecularFunction	glutamate-gated receptor activity	GRIA2 GRIA3 GRIA4 GRIN2A	5.46e-07	17	80	4	GO:0004970
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.52e-07	75	80	6	GO:0098960
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	6.46e-07	77	80	6	GO:0005230
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	2.19e-06	775	80	14	GO:0017111
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential	GRIA2 GRIA3 GRIA4 GRIN2A	2.39e-06	24	80	4	GO:0099507
GeneOntologyMolecularFunction	neurotransmitter receptor activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	3.02e-06	100	80	6	GO:0030594
GeneOntologyMolecularFunction	pyrophosphatase activity	KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	5.48e-06	839	80	14	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	5.55e-06	840	80	14	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	KIF6 ABCA13 SHOC1 MACF1 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	5.55e-06	840	80	14	GO:0016818
GeneOntologyMolecularFunction	monoatomic ion channel activity	GABRE CACNB1 CACNB2 SLC26A7 TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.46e-05	459	80	10	GO:0005216
GeneOntologyMolecularFunction	helicase activity	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	4.14e-05	158	80	6	GO:0004386
GeneOntologyMolecularFunction	channel activity	GABRE CACNB1 CACNB2 SLC26A7 TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.58e-05	525	80	10	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	GABRE CACNB1 CACNB2 SLC26A7 TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.66e-05	526	80	10	GO:0022803
GeneOntologyMolecularFunction	gated channel activity	GABRE CACNB1 CACNB2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.74e-05	334	80	8	GO:0022836
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	POLG CHD9 CHD6 CHD7 FANCM TOP1 TOP2B	8.68e-05	262	80	7	GO:0140097
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.25e-04	193	80	6	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.40e-04	197	80	6	GO:0022834
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	CHD9 CHD6 CHD7 FANCM TOP2B	1.58e-04	127	80	5	GO:0008094
GeneOntologyMolecularFunction	calcium channel activity	CACNB1 CACNB2 TRPC1 GRIA3 GRIN2A	1.70e-04	129	80	5	GO:0005262
GeneOntologyMolecularFunction	catalytic activity, acting on a nucleic acid	POLG CHD9 CHD6 CHD7 DDX43 FANCM DHX29 TOP1 VARS1 TOP2B	2.48e-04	645	80	10	GO:0140640
GeneOntologyMolecularFunction	extracellularly glutamate-gated ion channel activity	GRIA2 GRIN2A	3.29e-04	7	80	2	GO:0005234
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNB1 CACNB2 TRPC1 GRIA3 GRIN2A	3.53e-04	151	80	5	GO:0015085
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD9 CHD6 CHD7	4.36e-04	37	80	3	GO:0140658
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP1 TOP2B	4.37e-04	8	80	2	GO:0003916
GeneOntologyMolecularFunction	glutamate-gated calcium ion channel activity	GRIA3 GRIN2A	4.37e-04	8	80	2	GO:0022849
GeneOntologyMolecularFunction	amyloid-beta binding	GRIA2 GRIA3 GRIA4 GRIN2A	7.54e-04	102	80	4	GO:0001540
GeneOntologyMolecularFunction	amino acid transmembrane transporter activity	GRIA2 GRIA3 GRIA4 GRIN2A	8.40e-04	105	80	4	GO:0015171
GeneOntologyMolecularFunction	insulin-like growth factor I binding	LRP2 ITGA6	1.20e-03	13	80	2	GO:0031994
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	GABRE CACNB1 CACNB2 SLC26A7 TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.23e-03	793	80	10	GO:0015075
GeneOntologyMolecularFunction	high voltage-gated calcium channel activity	CACNB1 CACNB2	1.40e-03	14	80	2	GO:0008331
GeneOntologyMolecularFunction	carboxylic acid transmembrane transporter activity	SLC26A7 GRIA2 GRIA3 GRIA4 GRIN2A	1.46e-03	207	80	5	GO:0046943
GeneOntologyMolecularFunction	organic acid transmembrane transporter activity	SLC26A7 GRIA2 GRIA3 GRIA4 GRIN2A	1.49e-03	208	80	5	GO:0005342
GeneOntologyMolecularFunction	microtubule minus-end binding	CEP290 MACF1	1.61e-03	15	80	2	GO:0051011
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH6	2.33e-03	18	80	2	GO:0008569
GeneOntologyMolecularFunction	monoatomic cation channel activity	CACNB1 CACNB2 TRPC1 GRIA2 GRIA3 GRIN2A	2.54e-03	343	80	6	GO:0005261
GeneOntologyMolecularFunction	insulin-like growth factor binding	LRP2 ITGA6	2.59e-03	19	80	2	GO:0005520
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 KIF6 DNAH6	2.79e-03	70	80	3	GO:0003777
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	GABRE CACNB1 CACNB2 SLC26A7 TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	3.26e-03	758	80	9	GO:0015318
GeneOntologyMolecularFunction	RNA helicase activity	DDX43 FANCM DHX29	3.80e-03	78	80	3	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX43 FANCM DHX29	4.08e-03	80	80	3	GO:0008186
GeneOntologyMolecularFunction	cytoskeletal protein binding	CACNB2 KIF6 LMO7 SYNE2 CEP290 MACF1 GRIA2 ARL8A EML1 USH1C DRG1	4.28e-03	1099	80	11	GO:0008092
GeneOntologyMolecularFunction	K63-linked polyubiquitin modification-dependent protein binding	OTUD7A OTUD7B	4.84e-03	26	80	2	GO:0070530
GeneOntologyMolecularFunction	transporter activity	GABRE CACNB1 CACNB2 SLC26A7 ABCA13 TRPC1 LRP2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.07e-03	1289	80	12	GO:0005215
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH6	5.60e-03	28	80	2	GO:0051959
GeneOntologyMolecularFunction	organic anion transmembrane transporter activity	SLC26A7 GRIA2 GRIA3 GRIA4 GRIN2A	6.45e-03	293	80	5	GO:0008514
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	GRIA3 GRIN2A	6.84e-03	31	80	2	GO:0099604
GeneOntologyMolecularFunction	amide binding	GRIA2 GRIA3 GRIA4 GRIN2A LEPR	7.02e-03	299	80	5	GO:0033218
GeneOntologyMolecularFunction	transmembrane transporter activity	GABRE CACNB1 CACNB2 SLC26A7 ABCA13 TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	7.23e-03	1180	80	11	GO:0022857
GeneOntologyMolecularFunction	tubulin binding	KIF6 CEP290 MACF1 ARL8A EML1 DRG1	7.41e-03	428	80	6	GO:0015631
GeneOntologyMolecularFunction	microtubule binding	KIF6 CEP290 MACF1 EML1 DRG1	7.92e-03	308	80	5	GO:0008017
GeneOntologyMolecularFunction	laminin binding	ITGA6 ITGA9	8.18e-03	34	80	2	GO:0043236
GeneOntologyMolecularFunction	peptide binding	CLTB GRIA2 GRIA3 GRIA4 GRIN2A	9.02e-03	318	80	5	GO:0042277
GeneOntologyBiologicalProcess	ligand-gated ion channel signaling pathway	TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	4.03e-07	40	78	5	GO:1990806
GeneOntologyBiologicalProcess	glutamate receptor signaling pathway	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.90e-06	59	78	5	GO:0007215
GeneOntologyBiologicalProcess	ionotropic glutamate receptor signaling pathway	GRIA2 GRIA3 GRIA4 GRIN2A	3.11e-06	27	78	4	GO:0035235
GeneOntologyBiologicalProcess	ciliary transition zone assembly	DZIP1L CEP290	1.41e-05	2	78	2	GO:1905349
GeneOntologyBiologicalProcess	resolution of meiotic recombination intermediates	SHOC1 FANCM TOP2B	4.08e-05	18	78	3	GO:0000712
GeneOntologyBiologicalProcess	regulation of postsynaptic membrane potential	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	6.20e-05	180	78	6	GO:0060078
GeneOntologyBiologicalProcess	synaptic transmission, glutamatergic	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.44e-04	132	78	5	GO:0035249
GeneOntologyCellularComponent	receptor complex	GABRE PTPRB TRPC1 LRP2 ITGA6 GRIA2 GRIA3 GRIA4 GRIN2A ITGA9 LEPR	1.00e-05	581	78	11	GO:0043235
GeneOntologyCellularComponent	ionotropic glutamate receptor complex	GRIA2 GRIA3 GRIA4 GRIN2A	2.38e-05	45	78	4	GO:0008328
GeneOntologyCellularComponent	terminal bouton	POLG GRIA2 GRIA3 GRIA4 GRIN2A	2.98e-05	96	78	5	GO:0043195
GeneOntologyCellularComponent	neurotransmitter receptor complex	GRIA2 GRIA3 GRIA4 GRIN2A	3.63e-05	50	78	4	GO:0098878
GeneOntologyCellularComponent	monoatomic ion channel complex	GABRE CACNB1 CACNB2 TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	8.26e-05	378	78	8	GO:0034702
GeneOntologyCellularComponent	AMPA glutamate receptor complex	GRIA2 GRIA3 GRIA4	1.89e-04	30	78	3	GO:0032281
GeneOntologyCellularComponent	postsynaptic density membrane	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	3.04e-04	157	78	5	GO:0098839
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	MALRD1 PTPRB SLC26A7 ABCA13 CLTB SEC16A LRP2 GRIA2 GRIA3 GRIA4 ARL8A GRIN2A VPS13B SEC13	3.07e-04	1307	78	14	GO:0030659
GeneOntologyCellularComponent	vesicle membrane	MALRD1 PTPRB SLC26A7 ABCA13 CLTB SEC16A LRP2 GRIA2 GRIA3 GRIA4 ARL8A GRIN2A VPS13B SEC13	3.53e-04	1325	78	14	GO:0012506
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH6	6.07e-04	10	78	2	GO:0036156
GeneOntologyCellularComponent	transmembrane transporter complex	GABRE CACNB1 CACNB2 TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	7.35e-04	523	78	8	GO:1902495
GeneOntologyCellularComponent	postsynaptic endocytic zone	CLTB GRIA2	7.40e-04	11	78	2	GO:0098843
GeneOntologyCellularComponent	L-type voltage-gated calcium channel complex	CACNB1 CACNB2	8.85e-04	12	78	2	GO:1990454
GeneOntologyCellularComponent	postsynaptic specialization membrane	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.35e-04	201	78	5	GO:0099634
GeneOntologyCellularComponent	transporter complex	GABRE CACNB1 CACNB2 TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	1.02e-03	550	78	8	GO:1990351
GeneOntologyCellularComponent	cell projection membrane	GABRE SYNE2 CLTB LRP2 MACF1 GRIA2 GRIN2A	1.13e-03	431	78	7	GO:0031253
GeneOntologyCellularComponent	axon terminus	POLG GRIA2 GRIA3 GRIA4 GRIN2A	1.14e-03	210	78	5	GO:0043679
GeneOntologyCellularComponent	leading edge membrane	GABRE SYNE2 MACF1 GRIA2 GRIN2A	1.14e-03	210	78	5	GO:0031256
GeneOntologyCellularComponent	dendrite membrane	GABRE GRIA2 GRIN2A	1.20e-03	56	78	3	GO:0032590
GeneOntologyCellularComponent	Fanconi anaemia nuclear complex	FANCB FANCM	1.40e-03	15	78	2	GO:0043240
GeneOntologyCellularComponent	neuron projection terminus	POLG GRIA2 GRIA3 GRIA4 GRIN2A	1.80e-03	233	78	5	GO:0044306
GeneOntologyCellularComponent	plasma membrane signaling receptor complex	ITGA6 GRIA2 GRIA3 GRIA4 GRIN2A ITGA9	1.97e-03	350	78	6	GO:0098802
GeneOntologyCellularComponent	cytoplasmic region	DNHD1 DZIP1L CLTB GRIA2 ARL8A DNAH6	2.27e-03	360	78	6	GO:0099568
GeneOntologyCellularComponent	plasma membrane protein complex	CACNB1 CACNB2 CLTB ITGA6 GRIA2 GRIA3 GRIA4 GRIN2A ITGA9	2.55e-03	785	78	9	GO:0098797
GeneOntologyCellularComponent	microtubule associated complex	DNHD1 KIF6 EML1 DNAH6	3.11e-03	161	78	4	GO:0005875
GeneOntologyCellularComponent	presynaptic active zone membrane	GRIA2 GRIA3 GRIA4	3.11e-03	78	78	3	GO:0048787
GeneOntologyCellularComponent	membrane protein complex	GABRE CACNB1 CACNB2 TRPC1 SYNE2 CLTB ITGA6 GRIA2 GRIA3 GRIA4 GRIN2A ITGA9 SEC13	3.46e-03	1498	78	13	GO:0098796
GeneOntologyCellularComponent	neuron projection membrane	GABRE GRIA2 GRIN2A	3.58e-03	82	78	3	GO:0032589
GeneOntologyCellularComponent	presynaptic membrane	CLTB GRIA2 GRIA3 GRIA4 GRIN2A	3.79e-03	277	78	5	GO:0042734
GeneOntologyCellularComponent	axonemal dynein complex	DNHD1 DNAH6	3.90e-03	25	78	2	GO:0005858
GeneOntologyCellularComponent	postsynaptic membrane	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.05e-03	405	78	6	GO:0045211
GeneOntologyCellularComponent	sarcoplasmic reticulum	CACNB1 CALU SYNE2	4.37e-03	88	78	3	GO:0016529
Domain	Iontro_rcpt	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	IPR001320
Domain	Lig_chan-Glu_bd	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	PF10613
Domain	Iono_rcpt_met	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	IPR001508
Domain	Glu/Gly-bd	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	IPR019594
Domain	Lig_chan-Glu_bd	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	SM00918
Domain	Lig_chan	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	PF00060
Domain	PBPe	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.16e-09	18	78	5	SM00079
Domain	P-loop_NTPase	DNHD1 CACNB1 CACNB2 KIF6 ABCA13 SULT1C3 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	3.47e-07	848	78	16	IPR027417
Domain	-	DNHD1 CACNB1 CACNB2 ABCA13 SULT1C3 CHD9 CHD6 CHD7 ARL8A DDX43 OLA1 FANCM DNAH6 DHX29 DRG1	3.83e-07	746	78	15	3.40.50.300
Domain	ANF_lig-bd_rcpt	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.38e-07	37	78	5	IPR001828
Domain	ANF_receptor	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.38e-07	37	78	5	PF01094
Domain	Peripla_BP_I	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.75e-07	39	78	5	IPR028082
Domain	BRK	CHD9 CHD6 CHD7	1.39e-06	6	78	3	SM00592
Domain	BRK_domain	CHD9 CHD6 CHD7	1.39e-06	6	78	3	IPR006576
Domain	BRK	CHD9 CHD6 CHD7	1.39e-06	6	78	3	PF07533
Domain	Helicase_C	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	5.64e-06	107	78	6	PF00271
Domain	HELICc	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	5.64e-06	107	78	6	SM00490
Domain	Helicase_C	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	5.95e-06	108	78	6	IPR001650
Domain	HELICASE_CTER	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	6.28e-06	109	78	6	PS51194
Domain	HELICASE_ATP_BIND_1	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	6.28e-06	109	78	6	PS51192
Domain	DEXDc	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	6.28e-06	109	78	6	SM00487
Domain	Helicase_ATP-bd	CHD9 CHD6 CHD7 DDX43 FANCM DHX29	6.62e-06	110	78	6	IPR014001
Domain	DNA/RNA_helicase_DEAH_CS	CHD6 CHD7 FANCM DHX29	1.34e-05	35	78	4	IPR002464
Domain	Cezanne-2	OTUD7A OTUD7B	1.72e-05	2	78	2	IPR033477
Domain	DEAH_ATP_HELICASE	CHD6 CHD7 FANCM DHX29	1.87e-05	38	78	4	PS00690
Domain	VDCC_L_bsu	CACNB1 CACNB2	1.03e-04	4	78	2	IPR000584
Domain	VGCC_beta4Aa_N	CACNB1 CACNB2	1.03e-04	4	78	2	PF12052
Domain	Chromo_domain	CHD9 CHD6 CHD7	1.33e-04	24	78	3	IPR023780
Domain	Chromo	CHD9 CHD6 CHD7	1.70e-04	26	78	3	PF00385
Domain	CHROMO_1	CHD9 CHD6 CHD7	2.13e-04	28	78	3	PS00598
Domain	CHROMO_2	CHD9 CHD6 CHD7	2.13e-04	28	78	3	PS50013
Domain	DUF3669_Znf	ZNF398 ZNF783	2.55e-04	6	78	2	IPR022137
Domain	G_OBG	OLA1 DRG1	2.55e-04	6	78	2	IPR031167
Domain	DUF3669	ZNF398 ZNF783	2.55e-04	6	78	2	PF12417
Domain	G_OBG	OLA1 DRG1	2.55e-04	6	78	2	PS51710
Domain	SNF2_N	CHD9 CHD6 CHD7	3.19e-04	32	78	3	IPR000330
Domain	Chromodomain-like	CHD9 CHD6 CHD7	3.19e-04	32	78	3	IPR016197
Domain	SNF2_N	CHD9 CHD6 CHD7	3.19e-04	32	78	3	PF00176
Domain	Chromo/shadow_dom	CHD9 CHD6 CHD7	3.49e-04	33	78	3	IPR000953
Domain	CHROMO	CHD9 CHD6 CHD7	3.49e-04	33	78	3	SM00298
Domain	Znf_A20	OTUD7A OTUD7B	3.57e-04	7	78	2	IPR002653
Domain	TGS-like	OLA1 DRG1	3.57e-04	7	78	2	IPR012676
Domain	ZF_A20	OTUD7A OTUD7B	3.57e-04	7	78	2	PS51036
Domain	zf-A20	OTUD7A OTUD7B	3.57e-04	7	78	2	PF01754
Domain	ZnF_A20	OTUD7A OTUD7B	3.57e-04	7	78	2	SM00259
Domain	SANT	CHD6 CHD7 SNAPC4	1.19e-03	50	78	3	SM00717
Domain	OTU	OTUD7A OTUD7B	1.30e-03	13	78	2	PF02338
Domain	SANT/Myb	CHD6 CHD7 SNAPC4	1.34e-03	52	78	3	IPR001005
Domain	Quinoprotein_ADH-like_supfam	WDR87 AASDH EML1	1.41e-03	53	78	3	IPR011047
Domain	-	MAN2A1 GBE1	1.52e-03	14	78	2	2.60.40.1180
Domain	Beta-grasp_dom	OLA1 DRG1	1.52e-03	14	78	2	IPR012675
Domain	Dynein_HC_stalk	DNHD1 DNAH6	1.52e-03	14	78	2	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH6	1.52e-03	14	78	2	IPR013602
Domain	DHC_N2	DNHD1 DNAH6	1.52e-03	14	78	2	PF08393
Domain	MT	DNHD1 DNAH6	1.52e-03	14	78	2	PF12777
Domain	-	OLA1 DRG1	1.52e-03	14	78	2	3.10.20.30
Domain	OTU	OTUD7A OTUD7B	1.75e-03	15	78	2	PS50802
Domain	DHC_fam	DNHD1 DNAH6	1.75e-03	15	78	2	IPR026983
Domain	Glyco_hydro_b	MAN2A1 GBE1	1.75e-03	15	78	2	IPR013780
Domain	Dynein_heavy_dom	DNHD1 DNAH6	1.75e-03	15	78	2	IPR004273
Domain	Dynein_heavy	DNHD1 DNAH6	1.75e-03	15	78	2	PF03028
Domain	OTU_dom	OTUD7A OTUD7B	1.75e-03	15	78	2	IPR003323
Domain	Integrin_alpha_C_CS	ITGA6 ITGA9	1.99e-03	16	78	2	IPR018184
Domain	MMR_HSR1	OLA1 DRG1	2.25e-03	17	78	2	PF01926
Domain	Integrin_alpha-2	ITGA6 ITGA9	2.52e-03	18	78	2	IPR013649
Domain	Integrin_alpha2	ITGA6 ITGA9	2.52e-03	18	78	2	PF08441
Domain	Integrin_alpha	ITGA6 ITGA9	2.52e-03	18	78	2	IPR000413
Domain	INTEGRIN_ALPHA	ITGA6 ITGA9	2.52e-03	18	78	2	PS00242
Domain	CH	LMO7 SYNE2 MACF1	2.54e-03	65	78	3	SM00033
Domain	Int_alpha_beta-p	ITGA6 ITGA9	2.81e-03	19	78	2	IPR013519
Domain	GTP_binding_domain	OLA1 DRG1	2.81e-03	19	78	2	IPR006073
Domain	Int_alpha	ITGA6 ITGA9	2.81e-03	19	78	2	SM00191
Domain	CH	LMO7 SYNE2 MACF1	3.14e-03	70	78	3	PF00307
Domain	-	LMO7 SYNE2 MACF1	3.27e-03	71	78	3	1.10.418.10
Domain	DEAD/DEAH_box_helicase_dom	DDX43 FANCM DHX29	3.53e-03	73	78	3	IPR011545
Domain	CH	LMO7 SYNE2 MACF1	3.53e-03	73	78	3	PS50021
Domain	DEAD	DDX43 FANCM DHX29	3.53e-03	73	78	3	PF00270
Domain	FG_GAP	ITGA6 ITGA9	3.77e-03	22	78	2	PS51470
Domain	CH-domain	LMO7 SYNE2 MACF1	3.81e-03	75	78	3	IPR001715
Domain	Actinin_actin-bd_CS	SYNE2 MACF1	4.12e-03	23	78	2	IPR001589
Domain	Spectrin	SYNE2 MACF1	4.12e-03	23	78	2	PF00435
Domain	ACTININ_2	SYNE2 MACF1	4.12e-03	23	78	2	PS00020
Domain	ACTININ_1	SYNE2 MACF1	4.12e-03	23	78	2	PS00019
Pathway	WP_NRXN1_DELETION_SYNDROME	GRIA2 GRIA3 GRIA4 GRIN2A	8.10e-07	18	59	4	M48098
Pathway	REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION	GRIA2 GRIA3 GRIA4 GRIN2A	1.57e-06	21	59	4	M838
Pathway	REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION	GRIA2 GRIA3 GRIA4 GRIN2A	1.91e-06	22	59	4	MM15104
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	GRIA2 GRIA3 GRIA4 GRIN2A	1.32e-05	35	59	4	MM15109
Pathway	WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION	GRIA2 GRIA3 GRIA4 GRIN2A	2.50e-05	41	59	4	M39655
Pathway	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	GRIA2 GRIA3 GRIA4	3.75e-05	16	59	3	MM15048
Pathway	REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS	GRIA2 GRIA3 GRIA4	4.54e-05	17	59	3	M5488
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	GRIA3 GRIA4 GRIN2A	7.55e-05	20	59	3	MM15485
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	GRIA3 GRIA4 GRIN2A	8.78e-05	21	59	3	M27736
Pathway	WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA	GRIA2 GRIA3 GRIA4	1.01e-04	22	59	3	M39795
Pathway	KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A LEPR	1.33e-04	272	59	7	M13380
Pathway	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	GRIA2 GRIA3 GRIA4	2.36e-04	29	59	3	MM15028
Pathway	WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL	CACNB1 GRIA3 GRIA4 GRIN2A	2.43e-04	73	59	4	MM16641
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	CACNB1 CACNB2 GRIA2 GRIA3 GRIA4 GRIN2A	2.44e-04	211	59	6	MM14502
Pathway	WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY	CACNB1 CACNB2 ITGA6 ITGA9	2.56e-04	74	59	4	M39462
Pathway	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC	CACNB1 CACNB2 ITGA6 ITGA9	2.56e-04	74	59	4	M16376
Pathway	REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS	GRIA2 GRIA3 GRIA4	2.88e-04	31	59	3	M7223
Pathway	KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM	CACNB1 CACNB2 ITGA6 ITGA9	3.97e-04	83	59	4	M8728
Pathway	REACTOME_PHASE_0_RAPID_DEPOLARISATION	CACNB1 CACNB2	4.74e-04	8	59	2	MM15197
Pathway	KEGG_DILATED_CARDIOMYOPATHY	CACNB1 CACNB2 ITGA6 ITGA9	5.41e-04	90	59	4	M835
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	GRIA2 GRIA3 GRIA4 GRIN2A	6.37e-04	94	59	4	M2843
Pathway	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES	CACNB1 CACNB2 GRIA2 GRIA3 GRIA4 GRIN2A	8.99e-04	270	59	6	M15514
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNB1 CACNB2	9.24e-04	11	59	2	MM14498
Pathway	REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING	CACNB1 CACNB2	9.24e-04	11	59	2	M26913
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	TOP1 TOP2B SEC13	9.30e-04	46	59	3	M27397
Pathway	WP_RETT_SYNDROME	TAF1B SYNE2 GRIN2A	1.05e-03	48	59	3	M39759
Pathway	REACTOME_PHASE_2_PLATEAU_PHASE	CACNB1 CACNB2	1.52e-03	14	59	2	MM15198
Pathway	REACTOME_PHASE_2_PLATEAU_PHASE	CACNB1 CACNB2	1.75e-03	15	59	2	M27456
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KNTC1 LMO7 ZSWIM5 DZIP1L TAF1B SYNE2 MACF1 GRIA2 GRIA3 GRIA4 CHD6 ARL8A TTC3 DNAH6 LYST TOP1 VARS1 TOP2B	4.50e-09	1442	81	18	35575683
Pubmed	Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients.	GRIA2 GRIA3 GRIA4	1.22e-08	3	81	3	18163426
Pubmed	Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.	GRIA2 GRIA3 GRIA4 GRIN2A	3.65e-08	15	81	4	9481670
Pubmed	A phylogenetic analysis reveals an unusual sequence conservation within introns involved in RNA editing.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	10688364
Pubmed	Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	28608780
Pubmed	AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	9221927
Pubmed	Interaction proteomics reveals brain region-specific AMPA receptor complexes.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	25337787
Pubmed	Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	17828255
Pubmed	The N-terminal domain modulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor desensitization.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	24652293
Pubmed	Electrophysiological properties of AMPA receptors are differentially modulated depending on the associated member of the TARP family.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	17409242
Pubmed	Aberrant formation of glutamate receptor complexes in hippocampal neurons of mice lacking the GluR2 AMPA receptor subunit.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	14561864
Pubmed	Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	10027300
Pubmed	Chromosomal localization of human glutamate receptor genes.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	1319477
Pubmed	AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	12692557
Pubmed	Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	12125045
Pubmed	AMPA receptor-mediated excitotoxicity in human NT2-N neurons results from loss of intracellular Ca2+ homeostasis following marked elevation of intracellular Na+.	GRIA2 GRIA3 GRIA4	4.86e-08	4	81	3	9648857
Pubmed	RNA editing in brain controls a determinant of ion flow in glutamate-gated channels.	GRIA2 GRIA3 GRIA4	1.21e-07	5	81	3	1717158
Pubmed	Differential regulation of AMPA receptor subunit trafficking by palmitoylation of two distinct sites.	GRIA2 GRIA3 GRIA4	1.21e-07	5	81	3	16129400
Pubmed	Allosteric modulation of AMPA-type glutamate receptors increases activity of the promoter for the neural cell adhesion molecule, N-CAM.	GRIA2 GRIA3 GRIA4	1.21e-07	5	81	3	9482932
Pubmed	Calcium-permeable AMPA receptor plasticity is mediated by subunit-specific interactions with PICK1 and NSF.	GRIA2 GRIA3 GRIA4	1.21e-07	5	81	3	15797551
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	SYNE2 CEP290 ITGA6 MACF1 CHD7 PRKG1 EML1 TOP2B DRG1	1.60e-07	358	81	9	32460013
Pubmed	Glutamate can act as a signaling molecule in mouse preimplantation embryos†.	GRIA2 GRIA3 GRIA4 GRIN2A	2.80e-07	24	81	4	35746896
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SEC16A CUL9 MACF1 CHD9 CHD6 CHD7 OLA1 KNL1	3.26e-07	282	81	8	23667531
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	OTUD7A MACF1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.10e-07	197	81	7	36604605
Pubmed	Glutamate receptor δ2 is essential for input pathway-dependent regulation of synaptic AMPAR contents in cerebellar Purkinje cells.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	21368048
Pubmed	Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	33981040
Pubmed	Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	10407040
Pubmed	Glutamate receptors in cortical plasticity: molecular and cellular biology.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	9016303
Pubmed	Glutamate receptors: brain function and signal transduction.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	9651535
Pubmed	TARP γ-2 and γ-8 Differentially Control AMPAR Density Across Schaffer Collateral/Commissural Synapses in the Hippocampal CA1 Area.	GRIA2 GRIA3 GRIA4	4.23e-07	7	81	3	27076426
Pubmed	Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea.	GRIA2 GRIA3 GRIA4	6.76e-07	8	81	3	23217150
Pubmed	Changes of several brain receptor complexes in the cerebral cortex of patients with Alzheimer disease: probable new potential pharmaceutical targets.	GRIA2 GRIA3 GRIA4	1.01e-06	9	81	3	24292102
Pubmed	Expression of glutamate receptor subunit genes during development of the mouse retina.	GRIA2 GRIA3 GRIA4	1.01e-06	9	81	3	9051806
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	GABRE GRIA2 GRIA3 GRIA4 GRIN2A	1.35e-06	81	81	5	22723691
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	KNTC1 CALU CLTB GBE1 CHD9 CHD7 AASDH OLA1 TOP1 VARS1 TOP2B KNL1 DRG1	1.56e-06	1103	81	13	34189442
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CACNB1 CACNB2 SYNE2 SEC16A MACF1 GRIA2 GRIA3 GRIA4 CHD7 GRIN2A EML1 TTC3	2.32e-06	963	81	12	28671696
Pubmed	The PDZ proteins PICK1, GRIP, and syntenin bind multiple glutamate receptor subtypes. Analysis of PDZ binding motifs.	GRIA2 GRIA3 GRIA4	2.64e-06	12	81	3	11891216
Pubmed	Deletion of olfactomedin 2 induces changes in the AMPA receptor complex and impairs visual, olfactory, and motor functions in mice.	GRIA2 GRIA3 GRIA4	3.42e-06	13	81	3	25218043
Pubmed	Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.	GRIA2 GRIA3 GRIA4 GRIN2A	3.78e-06	45	81	4	25979088
Pubmed	Organisation of human ER-exit sites: requirements for the localisation of Sec16 to transitional ER.	SEC16A SEC13	5.36e-06	2	81	2	19638414
Pubmed	Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II.	TOP1 TOP2B	5.36e-06	2	81	2	15680922
Pubmed	Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells.	GRIA3 GRIA4	5.36e-06	2	81	2	12670305
Pubmed	Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders.	GRIA2 GRIA4	5.36e-06	2	81	2	21984433
Pubmed	Control of kinetic properties of AMPA receptor channels by nuclear RNA editing.	GRIA3 GRIA4	5.36e-06	2	81	2	7992055
Pubmed	Distribution of voltage-dependent calcium channel beta subunits in the hippocampus of patients with temporal lobe epilepsy.	CACNB1 CACNB2	5.36e-06	2	81	2	10465427
Pubmed	Elimination of redundant synaptic inputs in the absence of synaptic strengthening.	GRIA3 GRIA4	5.36e-06	2	81	2	22090494
Pubmed	Involvement of AMPA receptor GluR2 and GluR3 trafficking in trigeminal spinal subnucleus caudalis and C1/C2 neurons in acute-facial inflammatory pain.	GRIA2 GRIA3	5.36e-06	2	81	2	22937151
Pubmed	Synaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3.	GRIA2 GRIA3	5.36e-06	2	81	2	12848940
Pubmed	Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: too little juice or a miswired brain?	GRIA2 GRIA3	5.36e-06	2	81	2	19933774
Pubmed	GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis.	GRIA2 GRIA3	5.36e-06	2	81	2	17472701
Pubmed	Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells.	TOP1 TOP2B	5.36e-06	2	81	2	25815590
Pubmed	Investigation of possible epistatic interactions between GRIA2 and GRIA4 variants on clinical outcomes in patients with major depressive disorder.	GRIA2 GRIA4	5.36e-06	2	81	2	23613500
Pubmed	Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4.	GRIA3 GRIA4	5.36e-06	2	81	2	18316356
Pubmed	Genetic analysis of GRIA2 and GRIA4 genes in migraine.	GRIA2 GRIA4	5.36e-06	2	81	2	24512576
Pubmed	Differential plasma membrane targeting of voltage-dependent calcium channel subunits expressed in a polarized epithelial cell line.	CACNB1 CACNB2	5.36e-06	2	81	2	10066897
Pubmed	Involvement of GluR2 and GluR3 subunit C-termini in the trigeminal spinal subnucleus caudalis and C1-C2 neurons in trigeminal neuropathic pain.	GRIA2 GRIA3	5.36e-06	2	81	2	21215292
Pubmed	Molecular heterogeneity of calcium channel beta-subunits in canine and human heart: evidence for differential subcellular localization.	CACNB1 CACNB2	5.36e-06	2	81	2	14762176
Pubmed	Endocytosis and recycling of AMPA receptors lacking GluR2/3.	GRIA2 GRIA3	5.36e-06	2	81	2	18195348
Pubmed	GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse.	GRIA3 GRIA4	5.36e-06	2	81	2	21690196
Pubmed	PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking.	GRIA2 GRIA3 GRIA4	6.67e-06	16	81	3	16055064
Pubmed	Esophageal Atresia / Tracheoesophageal Fistula Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY	FANCB CHD7 FANCM	6.67e-06	16	81	3	20301753
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	YTHDF1 LMO7 TAF1B MACF1 OLA1 TTC3 DHX29 TOP1 VARS1 TOP2B	7.13e-06	724	81	10	36232890
Pubmed	Prenatal expression of D-aspartate oxidase causes early cerebral D-aspartate depletion and influences brain morphology and cognitive functions at adulthood.	GRIA2 GRIA3 GRIN2A	8.08e-06	17	81	3	32185508
Pubmed	BDNF regulates spontaneous correlated activity at early developmental stages by increasing synaptogenesis and expression of the K+/Cl- co-transporter KCC2.	GRIA2 GRIA3 GRIN2A	9.68e-06	18	81	3	12588844
Pubmed	Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation.	GRIA2 GRIA3 GRIA4	9.68e-06	18	81	3	18311135
Pubmed	Arhgap22 Disruption Leads to RAC1 Hyperactivity Affecting Hippocampal Glutamatergic Synapses and Cognition in Mice.	GRIA2 GRIA3 GRIN2A	9.68e-06	18	81	3	34455539
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	LMO7 SYNE2 SEC16A MACF1 CHD6 CHD7	1.49e-05	225	81	6	12168954
Pubmed	NMDAR-dependent presynaptic homeostasis in adult hippocampus: Synapse growth and cross-modal inhibitory plasticity.	GRIA2 GRIA3	1.60e-05	3	81	2	36070750
Pubmed	Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to antipsychotic treatment in patients with schizophrenia.	GRIA2 GRIA4	1.60e-05	3	81	2	22094384
Pubmed	The number and distribution of AMPA receptor channels containing fast kinetic GluA3 and GluA4 subunits at auditory nerve synapses depend on the target cells.	GRIA3 GRIA4	1.60e-05	3	81	2	28397107
Pubmed	An inhalation anaesthesia approach for neonatal mice allowing streamlined stereotactic injection in the brain.	GRIA2 GRIA3	1.60e-05	3	81	2	32569783
Pubmed	Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex.	GRIA2 GRIA3	1.60e-05	3	81	2	36223737
Pubmed	Persistent synaptic scaling independent of AMPA receptor subunit composition.	GRIA2 GRIA3	1.60e-05	3	81	2	23864664
Pubmed	AMPA receptor anchoring at CA1 synapses is determined by N-terminal domain and TARP γ8 interactions.	GRIA2 GRIA3	1.60e-05	3	81	2	34426577
Pubmed	Superactivation of AMPA receptors by auxiliary proteins.	GRIA2 GRIA4	1.60e-05	3	81	2	26744192
Pubmed	Obsessive-compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology.	GRIA2 GRIN2A	1.60e-05	3	81	2	28608743
Pubmed	Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder.	GRIA2 GRIA4	1.60e-05	3	81	2	22057216
Pubmed	Linking supply to demand: the neuronal monocarboxylate transporter MCT2 and the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid receptor GluR2/3 subunit are associated in a common trafficking process.	GRIA2 GRIA3	1.60e-05	3	81	2	19453627
Pubmed	Opposing gradients of ribbon size and AMPA receptor expression underlie sensitivity differences among cochlear-nerve/hair-cell synapses.	GRIA2 GRIA3	1.60e-05	3	81	2	21248103
Pubmed	GluA2 (GluR2) regulates metabotropic glutamate receptor-dependent long-term depression through N-cadherin-dependent and cofilin-mediated actin reorganization.	GRIA2 GRIA3	1.60e-05	3	81	2	21248105
Pubmed	Identification of rat EMAP, a delta-glutamate receptor binding protein.	GRID1 EML1	1.60e-05	3	81	2	11829466
Pubmed	Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.	GRIA2 GRIA3	1.60e-05	3	81	2	15144856
Pubmed	The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn.	GRIA2 GRIA3	1.60e-05	3	81	2	9892356
Pubmed	Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase.	GRIA2 GRIA3	1.60e-05	3	81	2	12700243
Pubmed	Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells.	GRIA3 GRIA4	1.60e-05	3	81	2	12172541
Pubmed	Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors.	GRIA2 GRIA3	1.60e-05	3	81	2	23595422
Pubmed	Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β.	TOP1 TOP2B	1.60e-05	3	81	2	21542140
Pubmed	Elevated GRIA1 mRNA expression in Layer II/III and V pyramidal cells of the DLPFC in schizophrenia.	GRIA2 GRIN2A	1.60e-05	3	81	2	17942280
Pubmed	Loss of Frrs1l disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalities.	GRIA2 GRIA4	1.60e-05	3	81	2	30692144
Pubmed	MACF1 links Rapsyn to microtubule- and actin-binding proteins to maintain neuromuscular synapses.	MACF1 TOP2B	1.60e-05	3	81	2	30842214
Pubmed	AMPA receptor alterations precede mossy fiber sprouting in young children with temporal lobe epilepsy.	GRIA2 GRIA3	1.60e-05	3	81	2	15145077
Pubmed	Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain.	GRIA2 GRIA3	1.60e-05	3	81	2	28290985
Pubmed	Tetratricopeptide repeat domain 3 overexpression tends to form aggregates and inhibit ubiquitination and degradation of DNA polymerase γ.	POLG TTC3	1.60e-05	3	81	2	29290964
Pubmed	Eliminating Glutamatergic Input onto Horizontal Cells Changes the Dynamic Range and Receptive Field Organization of Mouse Retinal Ganglion Cells.	GRIA2 GRIA4	1.60e-05	3	81	2	29352045
Pubmed	Long-term upregulation of cortical glutamatergic AMPA receptors in a mouse model of chronic visceral pain.	GRIA2 GRIA3	1.60e-05	3	81	2	26585043
Pubmed	Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors.	GRIA2 GRIA3	1.60e-05	3	81	2	14687553
Pubmed	Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2.	GRIA2 GRIA3	1.60e-05	3	81	2	29180434
Pubmed	The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.	CHD6 CHD7	1.60e-05	3	81	2	28533432
Pubmed	Synaptic AMPA receptor plasticity and behavior.	GRIA3 GRIA4	1.60e-05	3	81	2	19217372
Pubmed	Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.	TOP1 TOP2B	1.60e-05	3	81	2	9049244
Interaction	GRIA1 interactions	TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.18e-06	86	80	6	int:GRIA1
GeneFamily	Glutamate ionotropic receptor AMPA type subunits	GRIA2 GRIA3 GRIA4	1.19e-07	4	57	3	1200
GeneFamily	Topoisomerases	TOP1 TOP2B	1.45e-04	6	57	2	1050
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	CHD6 CHD7 SNAPC4	6.22e-04	53	57	3	532
GeneFamily	OTU domain containing	OTUD7A OTUD7B	1.29e-03	17	57	2	669
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA6 ITGA9	1.45e-03	18	57	2	1160
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	FANCB FANCM	1.79e-03	20	57	2	548
GeneFamily	Calcium voltage-gated channel subunits	CACNB1 CACNB2	3.02e-03	26	57	2	253
GeneFamily	Calcium voltage-gated channel subunits\|Membrane associated guanylate kinases	CACNB1 CACNB2	3.02e-03	26	57	2	904
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PTPRB SYNE2 ITGA6 MACF1 CHD7 LEPR SMAD5	8.13e-08	200	81	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRIA2 GRIA3 GRID1 GRIN2A PRKG1	8.10e-07	175	81	6	d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRIA2 GRIA3 GRID1 GRIN2A PRKG1	8.10e-07	175	81	6	454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB GVINP1 LMO7 SYNE2 ITGA6 LYST	8.94e-07	178	81	6	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 LMO7 SHOC1 ITGA6 PRKG1	9.24e-07	179	81	6	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	COVID-19-kidney-CD-IC-A\|kidney / Disease (COVID-19 only), tissue and cell type	CACNB2 SLC26A7 LMO7 SHOC1 ITGA6 PRKG1	1.05e-06	183	81	6	5c7597a5b2bf6a481ca2c7e68560179214150fa0
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF6 DZIP1L SYNE2 CEP290 MDH1B DNAH6	1.61e-06	197	81	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	(11)_FOXN4+-(2)_GFP_FOXI1\|(11)_FOXN4+ / shred by cell type by condition	SYNE2 CEP290 SEC16A TTC3 DHX29 SMAD5	1.66e-06	198	81	6	76d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PTPRB SYNE2 ITGA6 MACF1 LEPR SMAD5	1.76e-06	200	81	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 PARL SHOC1 PRKG1	1.28e-05	165	81	5	9bd332e5ede759a00a47728ea5558c215efdd77a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6 PRKG1	1.35e-05	167	81	5	edc5f04584b44f99ff9a62bbe0dab6fc044fb334
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 MROH2A LRP2 GRIA4 DNAH6	1.43e-05	169	81	5	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 SLC26A7 CUL9 GRIA3 ZNF783	1.52e-05	171	81	5	dd37e1693a5cfc42e40992d504f92048a8038b52
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6 PRKG1	1.70e-05	175	81	5	77c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6 PRKG1	1.70e-05	175	81	5	98947a226b5a2ac7091ff9d34243ea7736add973
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB GVINP1 LMO7 SYNE2 ITGA6	1.79e-05	177	81	5	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB GVINP1 LMO7 SYNE2 ITGA6	1.79e-05	177	81	5	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB GVINP1 LMO7 SYNE2 ITGA6	1.79e-05	177	81	5	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF6 ZSWIM5 MDH1B LRP2 USH1C	1.84e-05	178	81	5	58857bb8c13e0e1c6d9f5c1258f00fff62063d68
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF6 ZSWIM5 MDH1B LRP2 USH1C	1.84e-05	178	81	5	8b7df6ab8709d9ab9dff97677cc4561aec2745bc
ToppCell	droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF6 ZSWIM5 MDH1B LRP2 USH1C	1.84e-05	178	81	5	b0baf5667e3301898b3e45e974b8a8530af6a338
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	SYNE2 ZNF398 GBE1 CUL9 FANCM	1.89e-05	179	81	5	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	COVID-19-kidney-vSMC/Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNB2 GRIA2 GRID1 GRIN2A PRKG1	1.89e-05	179	81	5	111b1084f73306bdeffaaf240e7dbb4f5bf33de1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 GRIA3 PRKG1 ITGA9 FAM162B	1.89e-05	179	81	5	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 LMO7 SHOC1 ITGA6	1.99e-05	181	81	5	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD9 TTC3 LYST TOP2B	2.05e-05	182	81	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD9 TTC3 LYST TOP2B	2.05e-05	182	81	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD9 LYST VARS1 TOP2B	2.05e-05	182	81	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 GRIA3 PRKG1 ITGA9 FAM162B	2.10e-05	183	81	5	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIF6 TRPC1 DZIP1L PRKG1 FAM162B	2.16e-05	184	81	5	55dde9c4eebac2a33788c1ff1d8fe312d150fad4
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIF6 TRPC1 DZIP1L PRKG1 FAM162B	2.16e-05	184	81	5	7128a2be291544d3df3ed6c80f21ddda8437dcba
ToppCell	droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KIF6 TRPC1 DZIP1L PRKG1 FAM162B	2.16e-05	184	81	5	d14238f7b0b55a4c8d7040bea854bd221a66ac30
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 GRIN2A PRKG1 FAM162B	2.21e-05	185	81	5	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 GRIN2A PRKG1 FAM162B	2.21e-05	185	81	5	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 GRIN2A PRKG1 FAM162B	2.21e-05	185	81	5	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB2 GRIA3 PRKG1 ITGA9 FAM162B	2.21e-05	185	81	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 GRIN2A PRKG1 FAM162B	2.21e-05	185	81	5	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 LMO7 SHOC1 ITGA6	2.27e-05	186	81	5	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	facs-Skin-nan-18m-Mesenchymal-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIA3 PRKG1 ITGA9 DNAH6 LEPR	2.45e-05	189	81	5	29287525120be2953b76881ba3cfc4379c265e7a
ToppCell	facs-Skin-nan-18m-Mesenchymal-fibroblast\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIA3 PRKG1 ITGA9 DNAH6 LEPR	2.45e-05	189	81	5	7150dad9a92a715487c2d8130fa01b752ea69663
ToppCell	facs-Skin-nan-18m-Mesenchymal\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GRIA3 PRKG1 ITGA9 DNAH6 LEPR	2.45e-05	189	81	5	6e4c0effd5192fd00052abc048fdb87a74fb6554
ToppCell	COVID-19-Heart-EC_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PTPRB SYNE2 ITGA6 EML1 ITGA9	2.45e-05	189	81	5	fe49852ba15f948b384d6b4c258927c70b741357
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD1A PTPRB CALU CHD6 C16orf46	2.58e-05	191	81	5	6e1d00404d795ec7cf60f685e42e4ad9a16ac596
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD1A PTPRB CALU CHD6 C16orf46	2.58e-05	191	81	5	f158e393976b685b896a41871bda1ab65a8b58f5
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SYNE2 LRP2 MACF1 PRKG1 VPS13B	2.65e-05	192	81	5	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB LMO7 ITGA6 MACF1 TOP1	2.78e-05	194	81	5	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 DZIP1L MDH1B SHOC1 DNAH6	2.78e-05	194	81	5	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	LMO7 ABCA13 SYNE2 MACF1 DNAH6	2.92e-05	196	81	5	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	LMO7 ABCA13 SYNE2 MACF1 DNAH6	2.92e-05	196	81	5	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	KIF6 LMO7 SYNE2 DDX43 ITGA9	2.99e-05	197	81	5	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	PTPRB SYNE2 ITGA6 EML1 ITGA9	2.99e-05	197	81	5	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	PTPRB SYNE2 ITGA6 MACF1 CHD6	3.07e-05	198	81	5	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	LMO7 SYNE2 CEP290 TTC3 SMAD5	3.14e-05	199	81	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	COVID-19_Severe-immature_Neutrophil\|COVID-19_Severe / Disease condition and Cell class	ABCA13 SYNE2 CHD7 ITGA9 KNL1	3.14e-05	199	81	5	f82fa9d651e78f9ebbe6264e00a48c54b1786a69
ToppCell	COVID-19_Severe-immature_Neutrophil-\|COVID-19_Severe / Disease condition and Cell class	ABCA13 SYNE2 CHD7 ITGA9 KNL1	3.14e-05	199	81	5	42ea0c19c455bdb0ae89b428d09c333104c670dc
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	LMO7 SYNE2 CHD7 TTC3 DHX29	3.14e-05	199	81	5	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	PTPRB ITGA6 MACF1 LEPR SMAD5	3.22e-05	200	81	5	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	PTPRB ITGA6 MACF1 LEPR SMAD5	3.22e-05	200	81	5	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	COVID-19-kidney-Mito-rich_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	GABRE PTPRB SYNE2 EML1	1.42e-04	145	81	4	afed661aef990edb8e7012ab67ace56443520c9f
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	CACNB2 KIF6 LRP2 GRIA3	1.58e-04	149	81	4	649eb3441fa859591ea85f1ed5fcf08af272a32b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6	1.62e-04	150	81	4	87968ce885a4959616f0321f58517fe8029ba1b1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF6 LMO7 ABCA13 TRPC1	1.66e-04	151	81	4	16fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WDR87 MROH2A LRP2	1.79e-04	60	81	3	aa75fef294803ec6396c7d2c1f51d52bc4a5b43f
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2-Excitatory_Neuron.Slc17a7.Calb2-Vgll3_(Dentate_hilum?)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	WDR87 MROH2A LRP2	1.79e-04	60	81	3	069fbabfd0e48e5809ff01a026439fd0bd017779
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	1.79e-04	154	81	4	b6e982e341c6cfb6ff80a318078fcb10c36d182f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	1.79e-04	154	81	4	d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6	1.93e-04	157	81	4	c17c5c01fcb65c453690c265ec4f300ecdfefd34
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	GABRE CACNB1 LMO7 ITGA9	2.02e-04	159	81	4	8680b054622f573a82b1625fb93c2d5db81d1034
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNB1 ZNF268 OTUD7A AASDH	2.07e-04	160	81	4	778faada072e3abfa76a9a06fd4885fb63de7902
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A7 SHOC1 ITGA6 PRKG1	2.07e-04	160	81	4	1e210e526ea4d84fc58a798a26c0929bcb69fd89
ToppCell	5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNB2 GRIA4 GRIN2A DNAH6	2.33e-04	165	81	4	4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD1A CACNB1 TRPC1 GRID1	2.33e-04	165	81	4	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	KNTC1 FANCB SLC26A7 KNL1	2.33e-04	165	81	4	a5c3af634d2698f9a01cf074791756b7669f9fff
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD1A CACNB1 TRPC1 GRID1	2.33e-04	165	81	4	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	DNHD1 KNTC1 AASDH C16orf46	2.38e-04	166	81	4	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	COVID-19-kidney-Lymphatic_EC\|kidney / Disease (COVID-19 only), tissue and cell type	GABRE PTPRB PRKG1 ITGA9	2.44e-04	167	81	4	97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MAN2A1 LMO7 TTC3 OTUD7B	2.44e-04	167	81	4	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	YTHDF1 ZSWIM5 ZNF268 TRPC1	2.73e-04	172	81	4	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6	2.85e-04	174	81	4	5f4436863a40f8bca46e2989bca66c02b6be88d4
ToppCell	NS-moderate-d_0-4-Epithelial-Ionocyte\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CACNB2 MAN2A1 OTUD7A PRKG1	2.91e-04	175	81	4	a1e0a15c69211d6db2edeb101476f0f6e08b90c8
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRKG1 LEPR FAM162B KNL1	2.91e-04	175	81	4	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 SLC26A7 SHOC1 ITGA6	2.98e-04	176	81	4	25ebc8716aa44e44fce577701e3e82c6745a75ab
ToppCell	Int-URO-Lymphocyte-T_NK-gdT\|Int-URO / Disease, Lineage and Cell Type	SYNE2 CEP290 OTUD7A MDH1B	2.98e-04	176	81	4	15016a73c953d8d3e7c32a05ead5e7261f9914ca
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRB MROH2A LRP2 DNAH6	2.98e-04	176	81	4	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SLC26A7 SHOC1 ITGA6 PRKG1	2.98e-04	176	81	4	c2c4306476989bc2fb30dab00250ef7915842f13
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MACF1 CHD9 LYST TOP2B	2.98e-04	176	81	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	PIGN MAN2A1 CHD7 LYST	2.98e-04	176	81	4	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	3.04e-04	177	81	4	4943d040eee0f9dceaddc7498171281d170e271f
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KIF6 DZIP1L FAM162B KNL1	3.04e-04	177	81	4	2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	3.04e-04	177	81	4	3f2272b577c862dba8ccfb41184054bbd0ace6f5
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PIGN MAN2A1 CHD7 LYST	3.04e-04	177	81	4	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	3.04e-04	177	81	4	a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CACNB2 GRID1 PRKG1 FAM162B	3.04e-04	177	81	4	3645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCell	Ciliated_cells-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	KIF6 ABCA13 MDH1B DNAH6	3.04e-04	177	81	4	c38138fb5ad9766c2d240811210c854338cd612e
ToppCell	facs-Lung-EPCAM-18m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FANCB PTPRB ZSWIM5 LEPR	3.04e-04	177	81	4	2433924dcb085ebbe2545d476ebd7ee68e6092fb
ToppCell	tumor_Lung-Endothelial_cells-EPCs\|tumor_Lung / Location, Cell class and cell subclass	PTPRB ZSWIM5 ITGA6 EML1	3.04e-04	177	81	4	f8b152c09d56a97e8c0482fb1a3964c05f9dc8c5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAN2A1 TRPC1 ITGA6 GRIN2A	3.11e-04	178	81	4	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ABCA13 DZIP1L MDH1B DNAH6	3.11e-04	178	81	4	3b12db04006db6e94fc45649a4b3a63b92f21a61
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRE MACF1 PRKG1 ITGA9	3.11e-04	178	81	4	ad3de3e03a401dac64431a541899445262246347
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GABRE LMO7 ABCA13 MACF1	3.17e-04	179	81	4	6e965e424eebef50f0202cff75f458be395cfca1
Drug	DETC-MeSO	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A AASDH	4.99e-09	39	81	6	CID003035711
Drug	CGP 39653	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.03e-08	24	81	5	CID006437837
Drug	AC1NUW3V	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.58e-08	29	81	5	CID005462126
Drug	AC1L32TU	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	6.68e-08	30	81	5	CID000107831
Drug	cyclothiazide	GABRE CACNB1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	8.34e-08	103	81	7	CID000002910
Drug	alpha-methyl-4-carboxyphenylglycine	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	9.39e-08	32	81	5	CID000001222
Drug	D-CPPene	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.29e-07	34	81	5	CID006435801
Drug	3-pyridazinol 1-oxide	GRIA2 GRIA3 GRIA4	1.73e-07	4	81	3	CID000574311
Drug	R,S)-AMPA	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.74e-07	36	81	5	CID000001221
Drug	C6H12NO5P	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.74e-07	36	81	5	CID000104962
Drug	felbamate	GABRE GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.84e-07	70	81	6	CID000003331
Drug	thiokynurenic acid	GRIA2 GRIA3 GRIA4 GRIN2A	1.97e-07	15	81	4	CID003035667
Drug	riluzole	GABRE CACNB1 CACNB2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.98e-07	174	81	8	CID000005070
Drug	ifenprodil	GBE1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.00e-07	71	81	6	CID000003689
Drug	CGS 19755	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.30e-07	38	81	5	CID000068736
Drug	L-BMAA	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.30e-07	38	81	5	CID000028558
Drug	LY233536	GRIA2 GRIA3 GRIA4 GRIN2A	2.62e-07	16	81	4	CID000126239
Drug	HA-966	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.63e-07	39	81	5	CID000001232
Drug	AC1L1DME	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A LYST	2.78e-07	75	81	6	CID000002414
Drug	L000369	TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	3.41e-07	41	81	5	CID003931705
Drug	7-Cl-Thio-Kyna	GRIA2 GRIA3 GRIA4 GRIN2A	3.42e-07	17	81	4	CID003035668
Drug	AC1L1YEG	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000063114
Drug	Chicago acid	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000065740
Drug	CHEBI:570577	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID011334126
Drug	1-BCP	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000001370
Drug	irampanel	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID003038472
Drug	beta-N-oxalylaminoalanine	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000107978
Drug	LY395153	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000656707
Drug	5-h PCA	GRIA2 GRIA3 GRIA4	4.32e-07	5	81	3	CID000129091
Drug	Joro spider toxin	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.35e-07	43	81	5	CID000119582
Drug	MNQX	GRIA2 GRIA3 GRIA4 GRIN2A	4.38e-07	18	81	4	CID000130818
Drug	7-chlorokynurenic acid	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	5.50e-07	45	81	5	CID000001884
Drug	IDRA 21	GRIA2 GRIA3 GRIA4 GRIN2A	6.90e-07	20	81	4	CID000003688
Drug	2cmo	GRIA2 GRIA3 GRIA4	8.61e-07	6	81	3	CID006914597
Drug	YM928	GRIA2 GRIA3 GRIA4	8.61e-07	6	81	3	CID006918393
Drug	NS 102	GRIA2 GRIA3 GRIA4 GRIN2A	1.04e-06	22	81	4	CID005282252
Drug	CX516	GRIA2 GRIA3 GRIA4 GRIN2A	1.04e-06	22	81	4	CID000148184
Drug	LY354740	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.04e-06	51	81	5	CID000114827
Drug	YM90K	GRIA2 GRIA4 GRID1 GRIN2A	1.25e-06	23	81	4	CID005486547
Drug	thio-ATPA	GRIA2 GRIA3 GRIA4	1.50e-06	7	81	3	CID005289517
Drug	4,6-dichloroindole-2-carboxylic acid	GRIA2 GRIA3 GRIA4	1.50e-06	7	81	3	CID000127988
Drug	gavestinel	GRIA2 GRIA4 GRID1 GRIN2A	1.78e-06	25	81	4	CID006450546
Drug	GYKI 52466	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.99e-06	58	81	5	CID000003538
Drug	3,5-dihydroxyphenylglycine	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	2.36e-06	60	81	5	CID000108001
Drug	2,3-PDCA	GRIA2 GRIA3 GRIA4	2.40e-06	8	81	3	CID000127037
Drug	homoibotenic acid	GRIA2 GRIA3 GRIA4	2.40e-06	8	81	3	CID000194385
Drug	1-hydroxypyrazole	GRIA2 GRIA3 GRIA4	2.40e-06	8	81	3	CID003016733
Drug	1-hydroxyimidazole	GRIA2 GRIA3 GRIA4	2.40e-06	8	81	3	CID003614351
Drug	gabapentin	GABRE CACNB1 CACNB2 GRIA2 GRIA4 GRID1 GRIN2A	2.40e-06	169	81	7	CID000003446
Drug	L-689,560	GRIA2 GRIA4 GRID1 GRIN2A	2.45e-06	27	81	4	CID000121918
Drug	aptiganel	GRIA2 GRIA4 GRID1 GRIN2A	2.85e-06	28	81	4	CID000060839
Drug	C-PP	GRIA2 GRIA4 GRID1 GRIN2A	2.85e-06	28	81	4	CID000001228
Drug	ketobemidone	GRIA2 GRIA4 GRID1 GRIN2A	3.30e-06	29	81	4	CID000010101
Drug	Ly294486	GRIA2 GRIA3 GRIA4	3.59e-06	9	81	3	CID005311255
Drug	1m5b	GRIA2 GRIA3 GRIA4	3.59e-06	9	81	3	CID000447081
Drug	isothiazol-3-one	GRIA2 GRIA3 GRIA4	3.59e-06	9	81	3	CID000096917
Drug	L-quisqualic acid	GABRE KNTC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	3.65e-06	180	81	7	CID000001209
Drug	cis-2,3-piperidine dicarboxylic acid	GRIA2 GRIA4 GRID1 GRIN2A	3.80e-06	30	81	4	CID000001226
Drug	LY293558	GRIA2 GRIA3 GRIA4 GRIN2A	3.80e-06	30	81	4	CID000127894
Drug	GYKI 53655	GRIA2 GRIA4 GRID1 GRIN2A	3.80e-06	30	81	4	CID000126757
Drug	LY235959	GRIA2 GRIA4 GRID1 GRIN2A	4.35e-06	31	81	4	CID000131938
Drug	NPC 12626	GRIA2 GRIA4 GRID1 GRIN2A	4.35e-06	31	81	4	CID000108099
Drug	4-methylglutamic acid	GRIA2 GRIA3 GRIA4 GRIN2A	4.35e-06	31	81	4	CID000005365
Drug	eliprodil	GRIA2 GRIA4 GRID1 GRIN2A	4.35e-06	31	81	4	CID000060703
Drug	L-Glutamic Acid	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	4.40e-06	68	81	5	DB00142
Drug	caffeine	CACNB1 CACNB2 CALU TRPC1 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A TOP2B SEC13	4.78e-06	562	81	11	CID000002519
Drug	Benzoates	GRIA2 GRIA3 GRIA4	5.11e-06	10	81	3	ctd:D001565
Drug	1-aminoindan-1,5-dicarboxylic acid	GRIA2 GRIA4 GRID1 GRIN2A	5.62e-06	33	81	4	CID000002071
Drug	6,7-dinitroquinoxaline	GRIA2 GRIA3 GRIA4 GRIN2A	5.62e-06	33	81	4	CID002724608
Drug	alpha-aminoadipate	GRIA2 GRIA4 GRID1 GRIN2A AASDH	6.25e-06	73	81	5	CID000000469
Drug	AP-5	CACNB2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	6.45e-06	128	81	6	CID000001216
Drug	0-ol	GRIA2 GRIA3 GRIA4	7.01e-06	11	81	3	CID000069892
Drug	J-ST	GRIA2 GRIA3 GRIA4	7.01e-06	11	81	3	CID005288655
Drug	sym 2206	GRIA2 GRIA3 GRIA4	7.01e-06	11	81	3	CID005039877
Drug	YM872	GRIA2 GRIA3 GRIA4	7.01e-06	11	81	3	CID000148200
Drug	aniracetam	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A LYST	7.05e-06	130	81	6	CID000002196
Drug	kainite	GRIA2 GRIA3 GRIA4 GRIN2A	7.16e-06	35	81	4	CID000164810
Drug	2-amino-3-phosphonopropionic acid	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	7.62e-06	76	81	5	CID000003857
Drug	PhTX-343	GRIA2 GRIA3 GRIA4 GRIN2A	8.03e-06	36	81	4	CID000159548
Drug	gacyclidine	GRIA2 GRIA4 GRID1 GRIN2A	8.03e-06	36	81	4	CID000176265
Drug	glutamic acid diethyl ester	GRIA2 GRIA4 GRID1 GRIN2A	8.03e-06	36	81	4	CID000073960
Drug	gamma-Glu-Gly	GRIA2 GRIA3 GRIA4 GRIN2A	8.98e-06	37	81	4	CID000100099
Drug	C-X6	GRIA2 GRIA3 GRIA4	9.33e-06	12	81	3	CID005288002
Drug	Atpa	GRIA2 GRIA3 GRIA4	9.33e-06	12	81	3	CID000002252
Drug	1NaPP1	GRIA2 GRIA3 GRIA4	9.33e-06	12	81	3	CID000004877
Drug	4CPG	GRIA2 GRIA4 GRID1 GRIN2A	1.00e-05	38	81	4	CID000005115
Drug	GAMs	GRIA2 GRIA3 GRIA4 GRIN2A	1.00e-05	38	81	4	CID000002935
Drug	QX-314	TRPC1 GRIA2 GRIA3 GRIA4 GRIN2A	1.11e-05	82	81	5	CID000003925
Drug	S 16020-2	CALU TOP1 TOP2B	1.21e-05	13	81	3	CID000177329
Drug	Naspm	GRIA2 GRIA3 GRIA4	1.21e-05	13	81	3	CID000129695
Drug	DE gel	CACNB2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.22e-05	143	81	6	CID000008146
Drug	AC1L1B1W	GABRE GRIA2 GRIA3 GRIA4 GRIN2A	1.25e-05	84	81	5	CID000001248
Drug	AC1L2J0B	TOP1 TOP2B	1.25e-05	2	81	2	CID000072943
Drug	methyl brevifolincarboxylate	TOP1 TOP2B	1.25e-05	2	81	2	CID005319518
Drug	A 62176	TOP1 TOP2B	1.25e-05	2	81	2	CID000132823
Drug	Kt 6528	TOP1 TOP2B	1.25e-05	2	81	2	CID000132714
Drug	AC1NNRU4	GRIA2 GRIA3 GRIA4 GRIN2A	1.36e-05	41	81	4	CID005126051
Drug	adamantane	GRIA2 GRIA3 GRIA4 GRIN2A	1.36e-05	41	81	4	CID000009238
Drug	memantine	GRIA2 GRIA3 GRIA4 GRID1 GRIN2A	1.40e-05	86	81	5	CID000004054
Drug	quinoxaline-2,3-dione	GRIA2 GRIA3 GRIA4	1.53e-05	14	81	3	CID011469229
Disease	CHARGE syndrome (implicated_via_orthology)	CHD9 CHD6 CHD7	6.17e-07	7	78	3	DOID:0050834 (implicated_via_orthology)
Disease	central nervous system disease (implicated_via_orthology)	GRIA2 GRIA3 GRIA4	9.71e-06	16	78	3	DOID:331 (implicated_via_orthology)
Disease	Schizophrenia	SETD1A CACNB2 SLC26A7 ABCA13 LRP2 GRIA2 GRIA3 GRIA4 GRID1 GRIN2A SMAD5	2.02e-05	883	78	11	C0036341
Disease	congenital heart disease (implicated_via_orthology)	LRP2 CHD9 CHD6 CHD7	3.43e-05	69	78	4	DOID:1682 (implicated_via_orthology)
Disease	Bipolar Disorder	CACNB2 ABCA13 POLG GRIA2 GRIA3 GRID1 GRIN2A ITGA9	3.83e-05	477	78	8	C0005586
Disease	sarcoma (is_implicated_in)	PTPRB KNL1	1.91e-04	8	78	2	DOID:1115 (is_implicated_in)
Disease	hypertension (is_implicated_in)	CACNB2 KIF6 ITGA9 LEPR	3.04e-04	121	78	4	DOID:10763 (is_implicated_in)
Disease	quality of life during menstruation measurement, dysmenorrheic pain measurement	GRIN2A VPS13B	3.74e-04	11	78	2	EFO_0007889, EFO_0009366
Disease	Withdrawal Symptoms	GRIA2 GRIN2A SMAD5	4.94e-04	58	78	3	C0087169
Disease	Drug Withdrawal Symptoms	GRIA2 GRIN2A SMAD5	4.94e-04	58	78	3	C0086189
Disease	Substance Withdrawal Syndrome	GRIA2 GRIN2A SMAD5	4.94e-04	58	78	3	C0038587
Disease	Malignant neoplasm of breast	KIF6 ZSWIM5 SYNE2 MACF1 OLA1 ITGA9 TTC3 TOP1 LEPR VPS13B	5.22e-04	1074	78	10	C0006142
Disease	neurodegenerative disease (implicated_via_orthology)	TRPC1 GRIA2 GRIA3 GRIA4	6.02e-04	145	78	4	DOID:1289 (implicated_via_orthology)
Disease	quinate measurement	GRID1 LEPR	7.08e-04	15	78	2	EFO_0021167
Disease	autism spectrum disorder (implicated_via_orthology)	TRPC1 CHD9 CHD6 CHD7	7.18e-04	152	78	4	DOID:0060041 (implicated_via_orthology)
Disease	phosphatidylcholine measurement	KIF6 MALRD1 SYNE2 MACF1 CHD7	9.49e-04	284	78	5	EFO_0010226
Disease	Bone marrow hypocellularity	FANCB FANCM	1.03e-03	18	78	2	C1855710
Disease	age at menopause	POLG PARL CHD6 CHD7 FANCM	1.25e-03	302	78	5	EFO_0004704
Disease	white matter hyperintensity measurement	CACNB2 SHOC1 GBE1 CHD6 GRIN2A	1.25e-03	302	78	5	EFO_0005665
Disease	Immunologic Deficiency Syndromes	CHD7 LEPR	1.68e-03	23	78	2	C0021051
Disease	mitochondrial DNA measurement	POLG CHD7 PRKG1 VARS1 LEPR	1.79e-03	328	78	5	EFO_0006312
Disease	HDL cholesterol change measurement	SYNE2 GRID1	1.83e-03	24	78	2	EFO_0007805
Disease	Fanconi Anemia	FANCB FANCM	1.99e-03	25	78	2	C0015625
Disease	PR interval	SYNE2 OTUD7A CUL9 MACF1 CHD6 ITGA9	2.00e-03	495	78	6	EFO_0004462
Disease	Pancytopenia	FANCB FANCM	2.15e-03	26	78	2	C0030312
Disease	Acute monocytic leukemia	FANCB FANCM	2.15e-03	26	78	2	C0023465
Disease	grip strength measurement	KNTC1 TAF1B GBE1 GRID1 OLA1	2.37e-03	350	78	5	EFO_0006941
Disease	coronary artery disease (is_implicated_in)	KIF6 PARL LEPR	2.39e-03	100	78	3	DOID:3393 (is_implicated_in)
Disease	status epilepticus (biomarker_via_orthology)	POLG GRIA2 GRIN2A	2.39e-03	100	78	3	DOID:1824 (biomarker_via_orthology)
Disease	Colorectal Carcinoma	CACNB1 CACNB2 LMO7 ABCA13 LRP2 GRID1 GRIN2A	2.57e-03	702	78	7	C0009402

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEEKFKKQWEEDWGS	USH1C	366	Q9Y6N9
KKQWEEDWGSKEQLL	USH1C	371	Q9Y6N9
DWEQTKDNKAQDWEK	CALR3	216	Q96L12
KDFLHIKEKYNNDWW	CACNB1	131	Q02641
LHEKFNQLWKKWVCD	GVINP1	1886	Q7Z2Y8
LTLEALWKNLKKDNW	ABCA13	2741	Q86UQ4
DELKDWIKFAQKRWI	CALU	91	O43852
GKEDLWEKLQYLWKS	AASDH	551	Q4L235
RTFWKEDKAFWKEDN	CCDC70	126	Q6NSX1
EDKAFWKEDNALWER	CCDC70	131	Q6NSX1
QEDKALWEEEKALWV	CCDC70	151	Q6NSX1
KQLEQKLKQAEAWWL	DNHD1	501	Q96M86
KLKQAEAWWLQLGKF	DNHD1	506	Q96M86
WLEWSDAEKKREELN	DHX29	466	Q7Z478
DDPNFWQKWAKKAEL	CHD7	1526	Q9P2D1
WQKWAKKAELDIDAL	CHD7	1531	Q9P2D1
DFLHVKEKFNNDWWI	CACNB2	146	Q08289
KEKFNNDWWIGRLVK	CACNB2	151	Q08289
KSLQIKEFIWCNKDW	C16orf46	161	Q6P387
NKWLIKIKEWVDKYD	OLA1	241	Q9NTK5
NKLLDWFKALFWKEE	ARL8A	6	Q96BM9
IEAKKEFDKWKEQEW	DZIP1L	246	Q8IYY4
EDEWQKEWNELIKLA	OTUD7B	251	Q6GQQ9
KENWKDKDLTEWRFQ	PTPRB	1216	P23467
WNFDDLLEKIWDYLK	DRG1	276	Q9Y295
KWWDIIDIQKKDAVK	MAN2A1	221	Q16706
KDIQKHKWFEGFNWE	PRKG1	611	Q13976
KDWFLSEEEFKLWNR	FANCM	676	Q8IYD8
EQGLLDKLKNKWWYD	GRIA2	776	P42262
LDKLKNKWWYDKGEC	GRIA3	791	P42263
SEAGVLDKLKNKWWY	GRIA4	776	P48058
LDKLKNKWWYDKGEC	GRIA4	781	P48058
WDLEWDLQEFKQKKA	POLG	486	P54098
VKLQKEFEVWWAEEA	KIF6	676	Q6ZMV9
WENLNKTWKERLEKL	MACF1	2221	O94854
KQFHEAWKKLIDWLE	MACF1	2681	O94854
LKEQDQKWQDDLAKW	LMO7	731	Q8WWI1
QKWQDDLAKWKDRRK	LMO7	736	Q8WWI1
IIEWKNLNEDGEIKW	LEPR	771	P48357
TDTWNKDKDWVLKIL	KNL1	661	Q8NG31
DVFENLWKLIDKAWQ	KNTC1	1356	P50748
LWKLIDKAWQNYDKI	KNTC1	1361	P50748
KWENFKLEINEKNSW	GABRE	226	P78334
WISKEKGEVWKQNKF	LRP2	4286	P98164
IDNLEKKQWITKWNE	ITGA6	1111	P23229
KDWEWGKDDNDNARL	OTUD7A	406	Q8TE49
VWKESFQVAAKWEKL	FANCB	311	Q8NB91
EAEKNRKENEDSWDW	ITGA9	1016	Q13797
WKQEKDEDFDWNLKA	MALRD1	1316	Q5VYJ5
NFWQKWAKKAEIDIE	CHD9	1421	Q3L8U1
FSEWDKLQQEWLKSK	DNAH6	896	Q9C0G6
DKWIQLLKEFKDEDW	GBE1	441	Q04446
NFWQKWAKIAELDTE	CHD6	1021	Q8TD26
KEELIRWEEGKKWQA	CEP290	1906	O15078
LEKFKDSWREIWKKD	C3orf33	226	Q6P1S2
ELLLDWKIWSKAEQG	LYST	1916	Q99698
DWLKDVCEKNKWSHK	MDH1B	46	Q5I0G3
LQDTGDLDVLKQKWW	GRID1	791	Q9ULK0
QAEWWELLFFIKKLD	CUL9	496	Q8IWT3
WWENKAEVQMKEKFL	CENATAC	106	Q86UT8
WDWQKEEKLADVKCS	EML1	356	O00423
IREEGLKWQKTKWAD	DDX43	176	Q9NXZ2
WRKENFNITWDDLKD	DDX43	216	Q9NXZ2
WNLAKKAKWREEAAL	FAM162B	141	Q5T6X4
QKEGDFRKEINKWWN	PARL	146	Q9H300
TWDQKAWEDKLIQFL	MROH2A	636	A6NES4
IKLWKEEEDGQWKEE	SEC13	191	P55735
AFLQEVWKWKEEKGD	VARS1	411	P26640
LSKEWWEKVCNFQAK	SULT1C3	31	Q6IMI6
ANWEAKKARLEWELK	SYF2	66	O95926
FDEWKKHIENQKAWK	TOP2B	616	Q02880
AQEIQKKMWDELDLW	SYNE2	3716	Q8WXH0
QKWEEARAKYLWKSE	TAF1B	416	Q53T94
EESLVINLEKAEWWK	SHOC1	351	Q5VXU9
GAFDQWWESKEEKAK	SETD1A	821	O15047
WKQGDEEEKWAEKAV	SMAD5	21	Q99717
QEWREKAKKDLEEWN	CLTB	126	P09497
EDKEWKFARAKLWLS	TRPC1	656	P48995
KLEEKSCWLQQLQKW	ZSWIM5	431	Q9P217
WKIDDLMDWHQENKD	ZNF268	156	Q14587
DKNKSIVWDEKKNQW	SEC16A	2126	O15027
EWEKLEEWQKELYKN	ZNF398	156	Q8TD17
DWFLQDLEREIKKWQ	TTC3	1546	P53804
FDDAFLKEWRLENWK	PIGN	301	O95427
KWDLWLFEGEKIVLQ	VPS13B	2996	Q7Z7G8
FEELLVTKWKNWEKA	SNAPC4	176	Q5SXM2
DLKKYWNVDKIDWGI	SLC26A7	426	Q8TE54
WKEEWEKRLLQEEEK	WDR87	1481	Q6ZQQ6
QEDKKLKWEEWKQVW	WDR87	1511	Q6ZQQ6
KKEEEQKWKWWEEER	TOP1	196	P11387
SQDKWKGKFDVQWIF	YTHDF1	466	Q9BYJ9
EWGKLEDWQKELYKH	ZNF783	156	Q6ZMS7
LNKDREWEKVGKWEN	GRIN2A	366	Q12879